https://www.cnbc.com/2020/12/14/australian-dollar-surges-on-record-iron-ore-prices.html

https://www.cnbc.com/2020/12/14/australian-dollar-surges-on-record-iron-ore-prices.html

https://www.cnbc.com/2020/12/10/pfizer-covid-vaccine-fda-panel-recommends-approval-for-emergency-use.html

https://www.cnbc.com/2020/12/10/pfizer-covid-vaccine-fda-panel-recommends-approval-for-emergency-use.html

https://www.cnbc.com/2020/12/09/chinas-covid-vaccine-from-sinopharm-is-86percent-effective-uae-says-.html

https://www.cnbc.com/2020/12/09/chinas-covid-vaccine-from-sinopharm-is-86percent-effective-uae-says-.html

https://www.cnbc.com/2020/12/08/stock-market-strategists-see-sp-500-at-4000-4500-in-2021.html

https://www.cnbc.com/2020/12/08/stock-market-strategists-see-sp-500-at-4000-4500-in-2021.html

https://www.cnbc.com/2020/12/07/brexit-sterling-drops-as-fears-rise-over-risk-of-no-deal.html

https://www.cnbc.com/2020/12/07/brexit-sterling-drops-as-fears-rise-over-risk-of-no-deal.html

https://www.cnbc.com/2020/12/03/how-the-uk-will-roll-out-the-covid-vaccine.html

https://www.cnbc.com/2020/12/03/how-the-uk-will-roll-out-the-covid-vaccine.html

https://www.cnbc.com/2020/12/02/uk-approves-pfizer-biontech-coronavirus-vaccine-for-use.html

https://www.cnbc.com/2020/12/02/uk-approves-pfizer-biontech-coronavirus-vaccine-for-use.html